he incidence and features of subclinical Cushing’s syndrome in women with polycystic ovaries
Journal Title: Міжнародний ендокринологічний журнал - Year 2017, Vol 13, Issue 3
Abstract
Background. The purpose of investigation is to study the incidence of subclinical Cushing’s syndrome in women with polycystic ovary syndrome (PCOS). Materials and methods. Under our supervision, there were 120 patients of fertile age with PCOS. The average age of patients was 25.5 ± 4.3 years. Twenty healthy women of corresponding age made a control group. The complex of researches, including clinical, biochemical, hormonal (luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, estradiol, progesterone, dehydroepiandrostendion, 17-hydroxyprogesterone, anti-Mullerian hormone, insulin on day 14 of cycle), was performed in all patients, as well as ultrasonography of the uterus and ovaries with folliculometry in dynamics, and also magnetic resonance imaging and survey of patients. Results. Patients were divided into three groups: with primary PCOS (19 %), with secondary PCOS and obesity (74 %), with secondary PCOS and subclinical Cushing’s syndrome (7 %). In the first group of patients, a significant decrease of pituitary and ovarian hormones has been registered on the background of hyperandrogenemia. In the third group of patients, a significant decrease of pituitary hormones was also detected on the background of hyperandrogenemia. Conclusions. The most significant violations in the system of pituitary-ovarian function were found in the third group of patients with subclinical Cushing’s syndrome, at that, a significant decrease in the functional state of pituitary-gonadal system was marked, namely decline of LH, FSH, estradiol and progesterone on the background of hyperandrogenemia and hypercortisolemia. The incidence of subclinical Cushing’s syndrome among women with PCOS is 6.6 %. In future, it is necessary to monitor in dynamics the probability of recovery of fertility in all groups of patients with PCOS
Authors and Affiliations
Yu. M. Urmanova, Z. Yu. Khalimova, G. D. Narimova, H. R. Madaminova, M. B. Abduvahabova, D. A. Alieva, D. Sh. Holova, H. O. Alimukhamedova, M. M. Karimova, F. S. Hodjaeva, H. K. Nasirova, N. T. Rihsieva
Keywords
Related Articles
- EP ID EP212632
- DOI 10.22141/2224-0721.13.3.2017.104112
- Views 38
- Downloads 0
Using ultra-rapid insulin analogs in children and adolescents with type 1 diabetes mellitus
Background. The purpose of the study was a retrospective comparative analysis of using insulin analogues of the prolonged and ultra-short action and human genetically engineered insulins of middle and short action in chi...
Peculiarities of changes in body fluid sectors in obesity found by studying its structure
Background. Timely diagnosis of excess body weight and obesity, by studying the body mass index and body structure parameters, including the characteristics of changes in its fluid sectors, is critical due to the signifi...
Use of Neurovitan in the Treatment of Endocrine Polyneuropathy
Neurovitan may be the drug of choice in the implementation of complex therapy of neurotropic vitamins in patients with endocrine pathology. Objectiv: to study the effectiveness of Neurovitan in the complex treatment of...
Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: laboratory criteria for the diagnosis and control of treatment efficacy
Non-classic congenital adrenal hyperplasia (NCAH) due to 21-hydroxylase deficiency is one of the actual causes of hyperandrogenic manifestations at different age intervals. Timely diagnosis of the disease requires evalua...
Fatal Outcome in Comorbidity Aggravated by Hypoglycemia
The paper presents a fatal case after severe hypoglycemia in 45-year-old patient with comorbidity. The combination of coronary heart disease, cardiosclerosis with atrial fibrillation, complicated by heart failure III sta...